| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $654K | +0.0% |
| R&D Expense | $53.1M | +8.1% |
| SG&A Expense | $15.4M | +28.2% |
| Operating Income | -$68.5M | -13.2% |
| Interest Expense | $205K | +125.3% |
| Pre-tax Income | -$66.4M | -12.0% |
| Net Income | -$66.4M | -212.0% |
| EPS (Basic) | -$12.40 | +65.9% |
| EPS (Diluted) | -$12.40 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $121.5M | +57.1% |
| Current Assets | $124.3M | +55.3% |
| Total Assets | $139.8M | +44.0% |
| Current Liabilities | $17.2M | +20.1% |
| Total Liabilities | $26.3M | +5.1% |
| Stockholders' Equity | $113.5M | +200.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.5M | -9.0% |
| Capital Expenditures | $115K | -82.9% |
| Investing Cash Flow | -$165K | +81.7% |
| Financing Cash Flow | $103.8M | — |
| Free Cash Flow | -$59.6M | -7.9% |
| +65.9% |